Argentina’s Milei Condemns Socialism At Davos, Warns Against ‘Left-Wing Doctors’ Attacking Capitalism
Newly elected right-wing Argentine President Javier Milei champions libertarian ideals in speech at the World Economic Forum in Davos.
argenx Announces Preliminary Q4 And FY23 Results: Expects 4Q23 Total Revenue Of ~$374M Vs $ 384.95M Est.; And FY23 Revenue Of ~$1.2B Vs. $1.22B Est.; Preliminary Unaudited December 31, 2023 Cash, Cash Equivalents, And Current Financial Assets Of ~$3.2B
Today, argenx also announced preliminary* global net VYVGART revenues for the fourth quarter and full-year 2023 of approximately $374 million and $1.2 billion, respectively.
As of December
Argenx’s Autoimmune Trial Stumble: Analysts Cut Price Targets, Warn of Risky Outcomes
Wednesday, Argenx SE (NASDAQ: ARGX) released topline results from the ADDRESS Phase 3 study evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with pemphigus vulgaris (PV) and
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Aclarion (NASDAQ:ACON) shares rose 70.0% to $0.49 during Thursday’s pre-market session. The market value of their outstanding…
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers MSP Recovery (NASDAQ:LIFW) shares increased by 38.0% to $2.94 during Wednesday’s regular session. The market value of…
Why Is European Drugmaker Argenx Stock Sinking Today?
Argenx SE (NASDAQ: ARGX) shares plunged after the company released topline results from the ADDRESS Phase 3 study evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with pemphigus vulgaris (PV) and
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)."
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Aclarion (NASDAQ:ACON) shares rose 75.8% to $0.51 during Wednesday’s pre-market session. The market value of their outstanding…